Nanotherapy for Cancer: Targeting and Multipurpose Approaches in Future Cancer Treatments

Nanotherapy for Cancer: Targeting and Multipurpose Approaches in Future Cancer Treatments

Mohammadesmail Nikfar1

1) Ph.D. Graduate in Mathematics, Doctor of Philosophy (Ph.D.) in Pure Mathematics, Mathematics Teacher, District 4 Department of Education, Tehran, Iran

IOI Code : ADAB-ACADDZ
Publication : The 2nd International Conference on Interdisciplinary Studies in Applied Sciences, Health Sciences, and Engineering, Naples, Italy(https://iahwconf.com)
Abstract :
    Despite advances in tumor biology research and the development of chemotherapy, cancer remains a prevalent and fatal disease. The primary obstacles to cancer treatment stem from tumor heterogeneity, drug resistance, and systemic toxicity. Nanoscale drug delivery systems—or nanotherapeutics—are gaining increasing importance as carriers for antineoplastic agents, owing to their targeting potential and multifunctionality. In this discussion, we will examine the current landscape of cancer therapy and explore potential strategies for overcoming existing treatment barriers through nanotherapeutics. Specifically, we will investigate rational design strategies for nanoparticles intended for targeted, multimodal drug delivery. Challenges such as particle clearance and, in the context of gene delivery, low efficiency, remain significant limitations for cancer nanotherapeutics. This is further complicated by the observation that particle properties which enhance cellular uptake or gene transfer often simultaneously increase cytotoxicity or in vivo clearance. Nanoparticle delivery systems can integrate these properties into a single carrier, increasing the likelihood that targeted tumor cells receive both agents in a precise, controlled ratio. Consequently, once an optimal drug ratio is established in the laboratory, it can be effectively translated to clinical practice. Furthermore, combining multiple agents within a single carrier can streamline manufacturing and administration processes, mitigate batch-to-batch variability, and reduce costs.

Keywords : nanoparticles gene therapy drug delivery cancer treatment